Male hypogonadism: Benefits and risks

Description

In this introductory presentation, Dr. Dohle – chairman of the EAU guidelines on male hypogonadism - gives a quick overview of hypogonadism, covering the age-related decline of testosterone levels, symptoms, and causes of hypogonadism. He also summarizes benefits of testosterone replacement therapy and its contraindications and risks.

Resume Dr. Dohle
Gert Dohle (1956) is associate professor of urology at Erasmus MC Rotterdam The Netherlands.

He studied medicine at the Free University of Amsterdam and graduated (MD) in 1983. From 1983 to 1985 he was a scientific resident at Leiden University at the department of cell biology (Prof H. Tanke) and urology (Prof U. Jonas). He continued as a resident in urology from 1985 to 1991 at the state university hospital Leiden, The Netherlands and continued as a staff member of the department of urology at Leiden University. In 1993 he was appointed staff member of urology at Erasmus University Rotterdam (head Prof F.H. Schröder).

In 2001 he finished his PhD on obstructions of male infertility. His main focus was on Andrology and male genital surgery. He has published more than 150 articles, mainly on andrological topics and several book chapters. He was the chairman of the EAU guidelines on male infertility from 2004 to 2010.

Currently, he is the chairman of the EAU guidelines group on male hypogonadism. He is board member of the European Society of Andrological Urology (ESAU) and of the European Academy of Andrology (EAA). Since 2013 he is associate editor of the Journal Andrology. In 2016 Dr. Dohle will organise the 9th European congress of Andrology in Rotterdam, The Netherlands.


 

Speakers

Gert Dohle, MD,Ph.D

Gert Dohle, MD,Ph.D
Erasmus MC Rotterdam
The Netherlands